天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11973
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

SPH3127 1399849-02-5
PF-03382792 1400811-63-3
JAK-IN-3 1400876-94-9
Lifastuzumab vedotin 1401812-88-1
Bermekimab 1401965-15-8
Psiguadial D 1402066-95-8
CKD-519 1402796-27-3
GSK572A 1403602-32-3
Begelomab 1403744-56-8
Muromonab 140608-64-6
Bococizumab 1407495-02-6
Ralpancizumab 1407495-04-8
Tenatumomab 1412891-40-7
VUF-11222 1414376-84-3
Sonelokimab 1414386-05-2
ERG240 1415683-79-2
Sovleplenib 1415792-84-5
Dapirolizumab pegol 1416147-64-2
Dynole 2-24 1416313-72-8
PR-924 1416709-79-9
Vevorisertib trihydrochloride 1416775-08-0
Phenanthriplatin 1416900-51-0
N 0861 141696-90-4
Xentuzumab 1417158-65-6
Utomilumab 1417318-27-4
PIM1-IN-1 1417630-95-5
TINK-IN-1 1417795-25-5
Sofituzumab vedotin 1418200-58-4
SiR-COOH 1418275-26-9
Tisotumab 1418628-81-5
Eldacimibe 141993-70-6
14-Epiandrographolide 142037-79-4
Lapisteride 142139-60-4
Lulizumab pegol 1421830-13-8
BI-9627 hydrochloride 1422252-46-7
Opicinumab 1422268-07-2
Tafasitamab 1422527-84-1
Acetazolamide sodium 1424-27-7
Org 13011 142494-12-0
Luvadaxistat 1425511-32-5
IND24 1426047-44-0
Lanadelumab 1426055-14-2
APOBEC3G-IN-1 14261-92-8
isomer-GAT 107 1426240-47-2
Labuxtinib 1426449-01-5
IHVR-17028 1428247-78-2
Pritelivir mesylate hydrate 1428321-10-1
HXJ42 1428640-39-4
(S)-Baxdrostat 1428652-16-7
STL1267 1429024-58-7
RapiFluor-MS 1429047-69-7
Trevogrumab 1429201-24-0
EN3356 1429329-63-4
H4R antagonist 1 1429375-54-1
Safingol hydrochloride 139755-79-6
ME-3221 139958-16-0
Romilkimab 1399584-78-1
Imalumab 1430205-07-4
RS 56812 143137-37-5
PI3Kδ-IN-3 1431540-99-6
1-[4-(1H-Imidazol-1-yl)phenyl]methanamine dihydrochloride 1431966-12-9
Carbaryl-d3 1433961-56-8
MPO-IN-3 1435469-45-6
Quetiapine-d8 Hemifumarate 1435938-24-1
RP 61499 143680-27-7
Larotinib 1438072-11-7
Glutaminase-IN-3 1439399-45-7
Lirequinil 143943-73-1
ML 315 1440251-53-5
Lanopepden mesylate 1441390-17-5
WIN 51,708 144177-30-0
MM-401 TFA 1442106-11-7
Calpain-2-IN-1 144231-85-6
Pasotuxizumab 1442657-12-6
Firivumab 1443004-15-6
Navivumab 1443004-16-7
Rofleponide 144459-70-1
VU 0469650 1443748-47-7
BMS-963272 1441057-15-3
TWIK-1/TREK-1-IN-3 1440532-33-1
GRGDSPK acetate 144027-77-0
Sinitrodil 143248-63-9
TRPV3 antagonist 74a 1432051-63-2
Triptoquinone A 142950-86-5
3,3-Dimethylbutanoic acid-d9 1399294-95-1
Enlimomab 142864-19-5
Usenamine A 1428417-60-0
Tentoxin-d3 1426437-58-2
Uplarafenib 1425485-87-5
Org-13011 fumarate 142494-13-1
Antitumor agent-87 1422527-88-5
TNIK-IN-7 1417795-24-4
Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride 1416771-72-6
Vamotinib 1416241-23-0
IRE1α kinase-IN-2 1414938-21-8
Edobacomab 141410-98-2
Silperisone HCl 140944-30-5
ZD-2138 140841-32-3
Dimethylaminomicheliolide HCl 1403357-80-1
EZH2-IN-13 1403255-41-3
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.